What is EXCELLtoINNOV? The project was envisioned to place iMM Lisboa in the forefront of R&D+I in immunity and infection, through the recruitment of an ERA Chair and establishment of a translational biomedical research hub anchored in Lisbon. The successful implementation of this strategy includes: 1) the development of a new research line at iMM Lisboa by the ERA Chair holder which will transversally impact other research areas at the institute; 2) the implementation of structural changes at iMM Lisboa to successfully follow the ERA Priorities Roadmap; 3) the expansion of overseas collaborations and an improved integration of iMM Lisboa in the regional, national and international business community.
Why a Forum and a database? To establish a translational biomedical research hub anchored in Lisbon that will leverage the national potential beyond borders and act as the interface of Europe with America and Africa, it’s key to create of a forum for overseas discussion in translational immunity and infection and a database gathering experts or companies in translational immunity and infection. The database goal is to establishing international collaborations under EU, or other (bi-national) international collaborative networks that require the participation of both academic and industrial partners. Registered users will be able to enter the experts registry and contact individuals or companies, and potentially start new collaborations in translational immunity and infection in Europe, Africa and America.
For more information visit our Forum for overseas discussion in translational immunity and infection.This will include news, seminars, job opportunities, funding opportunities, entrepreneurial opportunities, regulatory news, successful collaboration cases and other information regarding the project EXCELLtoINNOV. Forum Link: https://www.linkedin.com/groups/12026752
“This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 667824”.